Aug 5, 2026 04:07PM
Apr 30, 2026 04:30PM
Apr 28, 2026 08:01AM
Apr 28, 2026 08:01AM
Feb 26, 2026 04:05PM
Nov 18, 2025 08:01AM
Nov 18, 2025 08:00AM Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
Oct 29, 2025 04:15PM
Aug 6, 2025 04:15PM
May 7, 2025 04:05PM
Mar 3, 2025 04:23PM
Dec 30, 2024 06:33AM
Dec 16, 2024 08:00AM
Dec 16, 2024 08:00AM Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
Nov 6, 2024 04:05PM
Sep 3, 2024 07:09AM
Sep 3, 2024 07:08AM
Sep 3, 2024 07:08AM
Aug 6, 2024 05:01PM
Jul 31, 2024 08:53AM
May 1, 2024 04:57PM Emergent BioSolutions Reports First Quarter 2024 Financial Results
Mar 6, 2024 04:31PM
Mar 6, 2024 04:31PM
Feb 21, 2024 07:03AM
Feb 21, 2024 07:00AM
Nov 28, 2023 06:59AM
Nov 8, 2023 05:38PM
Aug 8, 2023 04:31PM Emergent BioSolutions Reports Financial Results for Second Quarter 2023
May 15, 2023 07:36AM
May 9, 2023 04:05PM
Mar 29, 2023 01:58PM
Feb 27, 2023 04:42PM
Feb 27, 2023 04:42PM
Feb 15, 2023 06:00AM
Feb 15, 2023 02:00AM Bavarian Nordic to Acquire Portfolio of Travel Vaccines from Emergent BioSolutions
Feb 15, 2023 02:00AM
Feb 15, 2023 02:00AM
Jan 9, 2023 06:59AM
Jan 9, 2023 06:59AM
Jan 9, 2023 06:59AM
Nov 14, 2022 06:31AM
Nov 14, 2022 06:30AM Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach
Nov 14, 2022 06:30AM
Nov 8, 2022 04:16PM
Nov 8, 2022 04:16PM
Sep 26, 2022 04:12PM
Sep 26, 2022 04:12PM
Aug 1, 2022 04:05PM
Aug 1, 2022 04:05PM Emergent BioSolutions Reports Financial Results for Second Quarter 2022
May 16, 2022 09:25AM

1,179,439 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All